BLT2 is expressed in PanINs, IPMNs, pancreatic cancer and stimulates tumour cell proliferation

British Journal of Cancer

Volumn 99, Issue 7, 2008, Pages 1064-1073

  Hennig, R ^a,g   Osman, T ^b   Esposito, I ^a,c   Giese, N ^b   Rao, S M ^d   Ding, X Z ^d   Tong, W G ^d   Buchler M W ^b   Yokomizo, T ^e   Friess, H ^a   Adrian, T E ^f  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d NORTHWESTERN UNIVERSITY   (United States)

^e KYUSHU UNIVERSITY   (Japan)

^f UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^g TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

BLT2; IPMN; Leukotriene B4; Pancreatic cancer; PanIN

Indexed keywords

LEUKOTRIENE B4 RECEPTOR; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL CULTURE; CELL INFILTRATION; CELL PROLIFERATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; GROWTH STIMULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL;

BASE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; DNA PRIMERS; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOTRIENE B4; LIGANDS; PANCREATIC NEOPLASMS; PANCREATITIS; RECEPTORS, LEUKOTRIENE B4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING;

EID: 53049109168     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604655     Document Type: Article

References (47)

1. Ahrendt SA, Pitt HA (2002) Surgical management of pancreatic cancer. Oncology (Huntingt) 16: 725-734
2. Choi JA, Kim EY, Song H, Kim C, Kim JH (2007) Reactive oxygen species are generated through a BLT2-linked cascade in Ras-transformed cells. Free Radic Biol Med 44(4): 624-634
3. Chua YJ, Cunningham D (2005) Adjuvant treatment for resectable pancreatic cancer. J Clin Oncol 23: 4532-4537
4. Chung JW, Kim GY, Mun YC, Ahn JY, Seong CM, Kim JH (2005) Leukotriene B4 pathway regulates the fate of the hematopoietic stem cells. Exp Mol Med 37: 45-50
5. Ding XZ, Hennig R, Adrian TE (2003) Lipoxygenase and cyclooxygenase metabolism: new insights in treatment and chemoprevention of pancreatic cancer. Mol Cancer 2: 10
6. Gunning WT, Kramer PM, Steele VE, Pereira MA (2002) Chemoprevention by lipoxygenase and leukotriene pathway inhibitors of vinyl carbamate-induced lung tumors in mice. Cancer Res 62: 4199-4201
7. Hennig R, Ding XZ, Tong WG, Schneider MB, Standop J, Friess H, Buchler MW, Pour PM, Adrian TE (2002) 5-Lipoxygenase and leukotriene B(4) receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissue. Am J Pathol 161: 421-428
8. Heukamp I, Kilian M, Gregor JI, Kiewert C, Schimke I, Kristiansen G, Walz MK, Jacobi CA, Wenger FA (2006) Impact of polyunsaturated fatty acids on hepato-pancreatic prostaglandin and leukotriene concentration in ductal pancreatic cancer - is there a correlation to tumour growth and liver metastasis? Prostaglandins Leukot Essent Fatty Acids 74: 223-233
9. Hicks A, Monkarsh SP, Hoffman AF, Goodnow Jr R (2007) Leukotriene B4 receptor antagonists as therapeutics for inflammatory disease: preclinical and clinical developments. Expert Opin Investig Drugs 16: 1909-1920
10. Hitt E (2002) Aspirin may lower risk of pancreatic cancer. Lancet Oncol 3: 518
11. Howard TJ (1996) Pancreatic adenocarcinoma. Curr Probl Cancer 20: 281-328
12. Hruban RH, Adsay NV, Albores-Saavedra J, Compton C, Garrett ES, Goodman SN, Kern SE, Klimstra DS, Kloppel G, Longnecker DS, Luttges J, Offerhaus GJ (2001) Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 25: 579-586
13. Hruban RH, Goggins M, Parsons J, Kern SE (2000) Progression model for pancreatic cancer. Clin Cancer Res 6: 2969-2972
14. Iizuka Y, Yokomizo T, Terawaki K, Komine M, Tamaki K, Shimizu T (2005) Characterization of a mouse second leukotriene B4 receptor, mBLT2: BLT2-dependent ERK activation and cell migration of primary mouse keratinocytes. J Biol Chem 280: 24816-24823
15. Itzkowitz SH, Yio X (2004) Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 287: G7-G17
16. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ (2006) Cancer statistics, 2006. CA Cancer J Clin 56: 106-130
17. Lin Y, Tamakoshi A, Wakai K, Kawamura T, Aoki R, Kojima M, Ohno Y (1998) Descriptive epidemiology of pancreatic cancer in Japan. J Epidemiol 8: 52-59
18. Lundeen KA, Sun B, Karlsson L, Fourie AM (2006) Leukotriene B4 receptors BLT1 and BLT2: expression and function in human and murine mast cells. J Immunol 177: 3439-3447
19. Luo J, Iwasaki M, Inoue M, Sasazuki S, Otani T, Ye W, Tsugane S (2007) Body mass index, physical activity and the risk of pancreatic cancer in relation to smoking status and history of diabetes: a large-scale population-based cohort study in Japan-the JPHC study. Cancer Causes Control 18: 603-612
20. Maitra A, Ashfaq R, Gunn CR, Rahman A, Yeo CJ, Sohn TA, Cameron JL, Hruban RH, Wilentz RE (2002) Cyclooxygenase 2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia: an immunohistochemical analysis with automated cellular imaging. Am J Clin Pathol 118: 194-201
21. Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, Beger H, Fernandez-Cruz L, Dervenis C, Lacaine F, Falconi M, Pederzoli P, Pap A, Spooner D, Kerr DJ, Buchler MW (2004) A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350: 1200-1210
22. Nielsen CK, Campbell JI, Ohd JF, Morgelin M, Riesbeck K, Landberg G, Sjolander A (2005) A novel localization of the G-protein-coupled CysLT1 receptor in the nucleus of colorectal adenocarcinoma cells. Cancer Res 65: 732-742
23. Nielsen CK, Ohd JF, Wikstrom K, Massoumi R, Paruchuri S, Juhas M, Sjolander A (2003) The leukotriene receptor CysLT1 and 5-lipoxygenase are upregulated in colon cancer. Adv Exp Med Biol 525: 201-204
24. Ohd JF, Nielsen CK, Campbell J, Landberg G, Lofberg H, Sjolander A (2003) Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas. Gastroenterology 124: 57-70
25. Oomi K, Amano M (1998) The epidemiology of pancreatic diseases in Japan. Pancreas 16: 233-237
26. Orlando RC (2002) Mechanisms of epithelial injury and inflammation in gastrointestinal diseases. Rev Gastroenterol Disord 2(Suppl 2): S2-S8
27. Paruchuri S, Hallberg B, Juhas M, Larsson C, Sjolander A (2002) Leukotriene D(4) activates MAPK through a Ras-independent but PKCepsilon-dependent pathway in intestinal epithelial cells. J Cell Sci 115: 1883-1893
28. Paruchuri S, Mezhybovska M, Juhas M, Sjolander A (2006) Endogenous production of leukotriene D4 mediates autocrine survival and proliferation via CysLT1 receptor signalling in intestinal epithelial cells. Oncogene 25: 6660-6665
29. Pek SB, Walsh MF (1984) Leukotrienes stimulate insulin release from the rat pancreas. Proc Natl Acad Sci USA 81: 2199-2202
30. Qiu D, Kurosawa M, Lin Y, Inaba Y, Matsuba T, Kikuchi S, Yagyu K, Motohashi Y, Tamakoshi A (2005) Overview of the epidemiology of pancreatic cancer focusing on the JACC Study. J Epidemiol 15(Suppl 2): S157-S167
31. Qiu H, Johansson AS, Sjostrom M, Wan M, Schroder O, Palmblad J, Haeggstrom JZ (2006) Differential induction of BLT receptor expression on human endothelial cells by lipopolysaccharide, cytokines, and leukotriene B4. Proc Natl Acad Sci USA 103: 6913-6918
32. Rose DP (1997) Dietary Fat, Fatty Acids and Breast Cancer. Breast Cancer 4: 7-16
33. Sampson AP (2000) The role of eosinophils and neutrophils in inflammation. Clin Exp Allergy 30(Suppl 1): 22-27
34. Shao WH, Del PA, Bock CB, Haribabu B (2006) Targeted disruption of leukotriene B4 receptors BLT1 and BLT2: a critical role for BLT1 in collagen-induced arthritis in mice. J Immunol 176: 6254-6261
35. Shin EH, Lee HY, Bae YS (2006) Leukotriene B4 stimulates human monocyte-derived dendritic cell chemotaxis. Biochem Biophys Res Commun 348: 606-611
36. Stat bite (2002) Pancreatic cancer incidence in US blacks and whites, 1973-1999. J Natl Cancer Inst 94: 1671
37. Stocken DD, Buchler MW, Dervenis C, Bassi C, Jeekel H, Klinkenbijl JH, Bakkevold KE, Takada T, Amano H, Neoptolemos JP (2005) Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer. Br J Cancer 92: 1372-1381
38. Tong WG, Ding XZ, Hennig R, Witt RC, Standop J, Pour PM, Adrian TE (2002) Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Clin Cancer Res 8: 3232-3242
39. Tong WG, Ding XZ, Talamonti MS, Bell RH, Adrian TE (2007) Leukotriene B4 receptor antagonist LY293111 induces S-phase cell cycle arrest and apoptosis in human pancreatic cancer cells. Anticancer Drugs 18: 535-541
40. Whitcomb DC (2004) Inflammation and Cancer V. Chronic pancreatitis and pancreatic cancer. Am J Physiol Gastrointest Liver Physiol 287: G315-G319
41. Woo CH, You HJ, Cho SH, Eom YW, Chun JS, Yoo YJ, Kim JH (2002) Leukotriene B(4) stimulates Rac-ERK cascade to generate reactive oxygen species that mediates chemotaxis. J Biol Chem 277: 8572-8578
42. Woutersen RA, Appel MJ, Garderen-Hoetmer A (1999a) Modulation of pancreatic carcinogenesis by antioxidants. Food Chem Toxicol 37: 981-984
43. Woutersen RA, Appel MJ, Garderen-Hoetmer A, Wijnands MV (1999b) Dietary fat and carcinogenesis. Mutat Res 443: 111-127
44. Yokomizo T, Izumi T, Chang K, Takuwa Y, Shimizu T (1997) A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature 387: 620-624
45. Yokomizo T, Izumi T, Shimizu T (2001) Leukotriene B4: metabolism and signal transduction. Arch Biochem Biophys 385: 231-241
46. Yokomizo T, Kato K, Terawaki K, Izumi T, Shimizu T (2000) A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. J Exp Med 192: 421-432
47. Yoo MH, Song H, Woo CH, Kim H, Kim JH (2004) Role of the BLT2, a leukotriene B4 receptor, in Ras transformation. Oncogene 23: 9259-9268